RENEURX
Live / Allowed — Published for opposition (as of 11 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99449649
- Mark type
- Stylized text
- Filed
- 17 Oct 2025
- Published for opposition
- 11 Aug 2026
- Attorney of record
- John V. Hobgood, Esquire
Goods and services
- Class 005 — Pharmaceuticals: Injection devices filled with cold temperature treatment pain relief preparations
- Class 010 — Medical apparatus: Medical devices in the nature of devices for injecting cold temperature treatment preparations for pain relief; Cryoneurolysis devices for physical therapy, rehabilitative and pain management purposes; Preparation unit for cryoneurolysis devices for use in treatment, namely, computer displays and computer monitors and controllers therefor used in direct association with medical cryoneurolysis devices; Medical devices for containing and delivering ice slurry for nerve treatment
Owner
- Brixton Biosciences, Inc., Cambridge, MA, US
- Brixton Biosciences, Inc., Cambridge, MA, US
Prosecution history
- 11 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Aug 2026 — PUBLISHED FOR OPPOSITION
- 05 Aug 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION E-MAILED
- 16 Mar 2026 — NON-FINAL ACTION WRITTEN
- 05 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 17 Oct 2025 — NEW APPLICATION ENTERED